2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Uterine Cervical Neoplasms
2
Endometriosis
2
Carcinoma, Renal Cell
2
Uterine Prolapse
1
Uterine Neoplasms
1
Uterine Cervical Dysplasia
1
Skin Neoplasms
1
Rectal Diseases
1
Pilonidal Sinus
1
Pancreatic Neoplasms
1
Pain, Postoperative
1
Ovarian Neoplasms
1
Neoplasms
1
Metrorrhagia
1
Hemorrhage
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Dysplastic Nevus Syndrome
1
Diverticulitis
1
Crohn Disease
1
Constipation
1
Colonic Diseases
1
Colitis, Ulcerative
1
Carcinoma, Squamous Cell
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Bile Duct Neoplasms
1
Interventions
Cisplatin
76
Radiotherapy
44
Cetuximab
40
pembrolizumab
39
Paclitaxel
34
Carboplatin
33
Docetaxel
30
Fluorouracil
25
Radiotherapy, Intensity-Modulated
23
Nivolumab
18
Drug Therapy
14
Radiation
12
Erlotinib Hydrochloride
9
cemiplimab
8
Magnetic Resonance Spectroscopy
8
Blood Specimen Collection
8
130-nm albumin-bound paclitaxel
8
durvalumab
7
atezolizumab
7
Cyclophosphamide
7
Afatinib
7
Surveys and Questionnaires
6
Surgical Procedures, Operative
6
Panitumumab
6
Leucovorin
6
Esophagectomy
6
Chemoradiotherapy
6
fludarabine
5
aldesleukin
5
Radiosurgery
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
Sutures
×
Clear all
NCT00586040
2009-04-10
PTB
Massachusetts General Hospital
Phase 2
Completed
40 enrolled